atopic dermatitis

News

NICE okays NHS funding for MS and eczema drugs

The UK's NICE endorsed regular NHS funding for big-selling drugs from Roche and Sanofi, changing its mind in guidance for the multiple sclerosis and eczema drugs.

News

Sanofi’s blockbuster-tipped Dupixent set for European launch...

Sanofi’s new atopic dermatitis treatment Dupixent has gained EU approval, setting it up for a launch across key European markets.

News

Sanofi’s dermatitis drug dupilumab fast-tracked by FDA

Drug could earn $2.8 billion if approved in AD and asthma

NICE okays NHS funding for MS and eczema drugs

Sanofi’s blockbuster-tipped Dupixent set for European launch...

Sanofi’s dermatitis drug dupilumab fast-tracked by FDA

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

Editor's Picks